TELA Bio’s management will be participating virtually in the H.C. Wainwright Annual
About
Investor Contact
332-895-3230
ir@telabio.com
Source:
2022 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.39 USD | -1.35% | -14.76% | -33.69% |
Apr. 15 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
Mar. 22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
TELA Bio’s management will be participating virtually in the H.C. Wainwright Annual
About
Investor Contact
332-895-3230
ir@telabio.com
Source:
2022 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-33.69% | 108M | |
-2.92% | 185B | |
-3.80% | 105B | |
-5.48% | 66.59B | |
+11.22% | 54.66B | |
+16.74% | 47.78B | |
+3.43% | 41.26B | |
+4.56% | 26.95B | |
+1.64% | 26.37B | |
+12.72% | 24.8B |